156 related articles for article (PubMed ID: 38147021)
21. XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.
Wang G; Li Y; Pan R; Yin X; Jia C; She Y; Huang L; Yang G; Chi H; Tian G
Aging (Albany NY); 2024 Jan; 16(1):872-910. PubMed ID: 38217545
[TBL] [Abstract][Full Text] [Related]
22. Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker.
Xu Y; Lin Z; Ji Y; Zhang C; Tang X; Li C; Liu T
Eur J Med Res; 2023 Oct; 28(1):438. PubMed ID: 37848933
[TBL] [Abstract][Full Text] [Related]
23. ARPC2: A Pan-Cancer Prognostic and Immunological Biomarker That Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion.
Huang S; Dong C; Li D; Xu Y; Wu J
Front Cell Dev Biol; 2022; 10():896080. PubMed ID: 35733852
[No Abstract] [Full Text] [Related]
24. A pan-cancer analysis to determine the prognostic analysis and immune infiltration of HSPA5.
Zhu RK; Zhang W; Zhang YX; Hui Z; Wang XW
Curr Cancer Drug Targets; 2023 May; ():. PubMed ID: 37157205
[TBL] [Abstract][Full Text] [Related]
25. RelB is a potential molecular biomarker for immunotherapy in human pan-cancer.
Wu J; Yu X; Zhu H; Chen P; Liu T; Yin R; Qiang Y; Xu L
Front Mol Biosci; 2023; 10():1178446. PubMed ID: 37388242
[No Abstract] [Full Text] [Related]
26. Identification and validation of
Li L; Li F; Xu Z; Li L; Hu H; Li Y; Yu S; Wang M; Gao L
Front Pharmacol; 2023; 14():1213891. PubMed ID: 37680718
[No Abstract] [Full Text] [Related]
27. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
28. High expression of COL10A1 is associated with poor prognosis in colorectal cancer.
Huang H; Li T; Ye G; Zhao L; Zhang Z; Mo D; Wang Y; Zhang C; Deng H; Li G; Liu H
Onco Targets Ther; 2018; 11():1571-1581. PubMed ID: 29593423
[TBL] [Abstract][Full Text] [Related]
29. Effect of miR-26a-5p on gastric cancer cell proliferation, migration and invasion by targeting COL10A1.
Li HH; Wang JD; Wang W; Wang HF; Lv JQ
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1186-1194. PubMed ID: 32096148
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
Liu P; Wang X; Pan L; Han B; He Z
Front Immunol; 2022; 13():901784. PubMed ID: 35720327
[TBL] [Abstract][Full Text] [Related]
31. Identification of a Novel Nomogram to Predict Progression Based on the Circadian Clock and Insights Into the Tumor Immune Microenvironment in Prostate Cancer.
Feng D; Xiong Q; Zhang F; Shi X; Xu H; Wei W; Ai J; Yang L
Front Immunol; 2022; 13():777724. PubMed ID: 35154101
[TBL] [Abstract][Full Text] [Related]
32. COL10A1-DDR2 axis promotes the progression of pancreatic cancer by regulating MEK/ERK signal transduction.
Wen Z; Sun J; Luo J; Fu Y; Qiu Y; Li Y; Xu Y; Wu H; Zhang Q
Front Oncol; 2022; 12():1049345. PubMed ID: 36530986
[TBL] [Abstract][Full Text] [Related]
33. [STIP1 correlates with tumor immune infiltration and prognosis as a potential immunotherapy target: a pan-cancer bioinformatics analysis].
Guan S; Shen Z; Lin M; Deng H; Fang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jul; 43(7):1179-1193. PubMed ID: 37488801
[TBL] [Abstract][Full Text] [Related]
34. Cancer-Associated Fibroblasts Hinder Lung Squamous Cell Carcinoma Oxidative Stress-Induced Apoptosis via METTL3 Mediated m
Li Y; Li X; Deng M; Ye C; Peng Y; Lu Y
Oxid Med Cell Longev; 2022; 2022():4320809. PubMed ID: 36246404
[TBL] [Abstract][Full Text] [Related]
35. PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer.
Wang Q; Wang X; Li J; Yin T; Wang Y; Cheng L
Sci Rep; 2024 Jan; 14(1):1778. PubMed ID: 38245572
[TBL] [Abstract][Full Text] [Related]
36. ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis.
Ning Y; Li Y; Wang H
Front Genet; 2023; 14():1108167. PubMed ID: 36713082
[No Abstract] [Full Text] [Related]
37. Immune Infiltration of MMP14 in Pan Cancer and Its Prognostic Effect on Tumors.
Li M; Li S; Zhou L; Yang L; Wu X; Tang B; Xie S; Fang L; Zheng S; Hong T
Front Oncol; 2021; 11():717606. PubMed ID: 34604053
[TBL] [Abstract][Full Text] [Related]
38. MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer.
Cheng B; Lai Y; Huang H; Peng S; Tang C; Chen J; Luo T; Wu J; He H; Wang Q; Huang H
Environ Toxicol; 2024 Feb; 39(2):927-941. PubMed ID: 37972062
[TBL] [Abstract][Full Text] [Related]
39. An Integrated Analysis Identified TAGLN2 As an Oncogene Indicator Related to Prognosis and Immunity in Pan-Cancer.
Pan T; Wang S; Wang Z
J Cancer; 2023; 14(10):1809-1836. PubMed ID: 37476180
[No Abstract] [Full Text] [Related]
40. Pan-cancer analysis of SYNGR2 with a focus on clinical implications and immune landscape in liver hepatocellular carcinoma.
Liu C; Qu Z; Zhao H; Wang P; Zhan C; Zhang Y
BMC Bioinformatics; 2023 May; 24(1):192. PubMed ID: 37170221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
